Hikma Gets More Time On Vascepa Response As Amarin CEO Exits

ANDA Sponsor Argued Unsuccessfully For A 45-Day Extension

 
• By Dean Rudge
  
Gavel
Hikma’s request for a 45-day extension would “seriously prejudice” the company , Amarin said • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin